Pruritus clinical trials at UC Davis
3 in progress, 1 open to eligible people
Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
open to eligible people ages 18 years and up
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.
Sacramento, California and other locations
Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
Sorry, in progress, not accepting new patients
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Sacramento, California and other locations
LB-P8 in Patients With PSC
Sorry, not currently recruiting here
The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.
Sacramento, California and other locations
Our lead scientists for Pruritus research studies include Christopher Bowlus, MD.
Last updated: